Real-world safety and clinical outcomes of apixaban in patients with cancer and atrial fibrillation
Background Patients with cancer and atrial fibrillation (AF) are at increased risk of both thromboembolism and bleeding. However, real-world data evaluating apixaban use in this population remain limited, particularly in Middle Eastern populations. Methods We conducted a retrospective observational cohort study at a te...